You have 9 free searches left this month | for more free features.

ER Breast Cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Resistance in ER+ Breast Cancer Patients:Translational Project

Recruiting
  • Breast Cancer
    • Aviano, Pordenone, Italy
    • +1 more
    Nov 8, 2023

    Older Women With ER+ Breast Cancer Who Omit Surgery

    Recruiting
    • Breast Cancer
      • Pittsburgh, Pennsylvania
        UPMC Magee Womens Hospital - Surgical Oncology
      Jun 13, 2023

      Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

      Not yet recruiting
      • Advanced Breast Cancer
      • Lebanon, New Hampshire
        Dartmouth Hitchcock Medical Center
      Jun 28, 2023

      Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

      Recruiting
      • Metastatic Breast Cancer
      • +3 more
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Sep 26, 2023

      Breast Cancer, ER Positive Breast Cancer Trial in Lebanon (Letrozole 2.5mg)

      Recruiting
      • Breast Cancer
      • ER Positive Breast Cancer
      • Letrozole 2.5mg
      • Lebanon, New Hampshire
      • +1 more
      Dec 19, 2022

      Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)

      Not yet recruiting
      • Metastatic Breast Cancer
      • (no location specified)
      Jun 2, 2023

      Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

      Not yet recruiting
      • Breast Cancer
      • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
      • Ottawa, Ontario, Canada
      • +1 more
      Jul 22, 2023

      Electronic Medical Record-Based Nudge to Reduce SLNB

      Recruiting
      • Breast Cancer
      • Estrogen-receptor-positive Breast Cancer
      • Column-based nudge in the EHR
      • No column-based nudge in the EHR
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Medical Center
      Aug 17, 2023

      ER+ Breast Cancer, Breast Cancer, Aromatase Inhibitors Trial in Boston (White Wine, Grape Juice)

      Not yet recruiting
      • ER+ Breast Cancer
      • +2 more
      • White Wine
      • Grape Juice
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Aug 1, 2022

      Estrogen Receptor-positive Breast Cancer Trial in Nashville (2-Week Ketogenic Diet, Letrozole)

      Recruiting
      • Estrogen Receptor-positive Breast Cancer
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Sep 20, 2022

      Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

      Not yet recruiting
      • Hormone Receptor-positive Breast Cancer
      • +2 more
      • Nashville, Tennessee
        Sarah Cannon Research Institute
      Oct 5, 2022

      Breast Cancer Trial in New York, Pittsburgh, Houston (Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions),

      Recruiting
      • Breast Cancer
      • Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions)
      • +2 more
      • New York, New York
      • +4 more
      Jun 29, 2022

      Metastatic Breast Cancer Trial (Estradiol)

      Not yet recruiting
      • Metastatic Breast Cancer
      • (no location specified)
      Feb 6, 2023

      Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

      Recruiting
      • Breast Cancer
      • Denver, Colorado
      • +4 more
      Dec 12, 2022

      ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

      Recruiting
      • ER+ Breast Cancer
      • 4FMFES-PET
      • Sherbrooke, Quebec, Canada
        Université deSherbrooke
      Jul 18, 2022

      Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

      Not yet recruiting
      • Breast Cancer
      • +4 more
      • (no location specified)
      Aug 31, 2023

      Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+

      Not yet recruiting
      • Breast Cancer
        • (no location specified)
        Aug 21, 2023

        ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer Trial in Luoyang, Shanghai (TFX06 tablet)

        Recruiting
        • ER+, HER2- Advanced Breast Cancer
        • Metastatic Breast Cancer
        • TFX06 tablet
        • Luoyang, Henan, China
        • +1 more
        Jun 25, 2023

        Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

        Active, not recruiting
        • Estrogen Receptor Positive Breast Cancer
        • Edmonton, Alberta, Canada
          Cross Cancer Institute
        Feb 1, 2023

        Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

        Not yet recruiting
        • Breast Cancer
        • Triple Negative Breast Cancer
        • Imatinib 400 MG Oral Tablet
        • Gothenburg, Sweden
          Barbro Linderholm
        Feb 1, 2023

        Breast Cancer, Neoadjuvant Trial in Wuhan (pyrotinib,Trastuzumab,carboplatin,Albumin paclitaxel)

        Recruiting
        • Breast Cancer
        • Neoadjuvant
        • pyrotinib,Trastuzumab,carboplatin,Albumin paclitaxel
        • Wuhan, Hubei, China
        • +1 more
        Aug 18, 2023

        Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

        Recruiting
        • Hormone Receptor Positive HER-2 Negative Breast Cancer
        • Shanghai, Shanghai, China
          Breast cancer institute of Fudan University Cancer Hospital
        Jun 12, 2023

        Breast Cancer Stage IV Trial in Irvine (Gallium-68)

        Recruiting
        • Breast Cancer Stage IV
        • Irvine, California
          Hoag Memorial Hospital Presbyterian
        May 26, 2023

        Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

        Active, not recruiting
        • Metastatic Breast Cancer
        • Springfield, Massachusetts
        • +2 more
        Nov 1, 2022